Induced Pluripotent Stem Cell-Derived Cardiac Progenitors Differentiate to Cardiomyocytes and Form Biosynthetic Tissues

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Christoforou, Nicolas ^a   Liau, Brian ^a   Chakraborty, Syandan ^a   Chellapan, Malathi ^a   Bursac, Nenad ^a   Leong, Kam W ^a  

^a Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; RED FLUORESCENT PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NKX2.5; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CARDIAC STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEART MUSCLE CELL; MEMBRANE ELECTROPHYSIOLOGY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING;

ACTION POTENTIALS; ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOPHENOTYPING; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCYTES, CARDIAC; TISSUE ENGINEERING; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

IPS; MAMMALIA;

EID: 84878990884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065963     Document Type: Article

References (62)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209.
2. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, et al. (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379: 895-904.
3. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, et al. (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489: 322-325.
4. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, et al. (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126: S29-37.
5. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, et al. (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126: S54-64.
6. Buckingham M, Meilhac S, Zaffran S, (2005) Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 6: 826-835.
7. Christoforou N, Miller RA, Hill CM, Jie CC, McCallion AS, et al. (2008) Mouse ES cell-derived cardiac precursor cells are multipotent and facilitate identification of novel cardiac genes. The Journal of clinical investigation 118: 894-903.
8. Kattman SJ, Huber TL, Keller GM, (2006) Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Developmental cell 11: 723-732.
9. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, et al. (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127: 1151-1165.
10. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, et al. (2006) Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127: 1137-1150.
11. Hidaka K, Lee JK, Kim HS, Ihm CH, Iio A, et al. (2003) Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J 17: 740-742.
12. Miller RA, Christoforou N, Pevsner J, McCallion AS, Gearhart JD, (2008) Efficient array-based identification of novel cardiac genes through differentiation of mouse ESCs. PLoS One 3: e2176.
13. Terami H, Hidaka K, Shirai M, Narumiya H, Kuroyanagi T, et al. (2007) Efficient capture of cardiogenesis-associated genes expressed in ES cells. Biochem Biophys Res Commun 355: 47-53.
14. Christoforou N, Oskouei BN, Esteso P, Hill CM, Zimmet JM, et al. (2010) Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PloS one 5: e11536.
15. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
16. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
17. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, et al. (2010) A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 120: 1125-1139.
18. Moretti A, Bellin M, Jung CB, Thies TM, Takashima Y, et al. (2010) Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J 24: 700-711.
19. Xu H, Yi BA, Wu H, Bock C, Gu H, et al. (2012) Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res 22: 142-154.
20. Zwi-Dantsis L, Gepstein L, (2012) Induced pluripotent stem cells for cardiac repair. Cell Mol Life Sci 69: 3285-3299.
21. Gepstein L, Ding C, Rahmutula D, Wilson EE, Yankelson L, et al. (2010) In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. Stem Cells 28: 2151-2161.
22. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, et al. (2009) Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci U S A 106: 16568-16573.
23. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, et al. (2011) Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109: 47-59.
24. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM, (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44: 41-50.
25. Kim C, Majdi M, Xia P, Wei KA, Talantova M, et al. (2010) Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 19: 783-795.
26. Grskovic M, Javaherian A, Strulovici B, Daley GQ, (2011) Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 10: 915-929.
27. Schaaf S, Shibamiya A, Mewe M, Eder A, Stohr A, et al. (2011) Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 6: e26397.
28. Davis RP, van den Berg CW, Casini S, Braam SR, Mummery CL, (2011) Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development. Trends Mol Med 17: 475-484.
29. Liau B, Christoforou N, Leong KW, Bursac N, (2011) Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 32: 9180-9187.
30. Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R, Schwanke K, et al. (2013) Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J 34: 1134-1146.
31. Lien CL, Wu C, Mercer B, Webb R, Richardson JA, et al. (1999) Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development 126: 75-84.
32. Klug MG, Soonpaa MH, Koh GY, Field LJ, (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98: 216-224.
33. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, et al. (2009) Reprogramming of murine and human somatic cells using a single polycistronic vector. Proceedings of the National Academy of Sciences of the United States of America 106: 157-162.
34. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, et al. (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell stem cell 3: 340-345.
35. Bursac N, Parker KK, Iravanian S, Tung L, (2002) Cardiomyocyte cultures with controlled macroscopic anisotropy: a model for functional electrophysiological studies of cardiac muscle. Circ Res 91: e45-54.
36. Bian W, Liau B, Badie N, Bursac N, (2009) Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc 4: 1522-1534.
37. Klinger R, Bursac N, (2008) Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells. IEEE engineering in medicine and biology magazine: the quarterly magazine of the Engineering in Medicine & Biology Society 27: 72-80.
38. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature biotechnology 26: 795-797.
39. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
40. Gulick J, Subramaniam A, Neumann J, Robbins J, (1991) Isolation and characterization of the mouse cardiac myosin heavy chain genes. The Journal of biological chemistry 266: 9180-9185.
41. Saga Y, Kitajima S, Miyagawa-Tomita S, (2000) Mesp1 expression is the earliest sign of cardiovascular development. Trends in cardiovascular medicine 10: 345-352.
42. Kubalak SW, Miller-Hance WC, O'Brien TX, Dyson E, Chien KR, (1994) Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem 269: 16961-16970.
43. Mahdavi V, Izumo S, Nadal-Ginard B, (1987) Developmental and hormonal regulation of sarcomeric myosin heavy chain gene family. Circ Res 60: 804-814.
44. Matsuura K, Honda A, Nagai T, Fukushima N, Iwanaga K, et al. (2009) Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 119: 2204-2217.
45. Takamiya M, Haider KH, Ashraf M, (2011) Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS One 6: e25265.
46. Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, et al. (2009) Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 23: 4168-4180.
47. Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J, (1994) Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75: 233-244.
48. Zhao XY, Li W, Lv Z, Liu L, Tong M, et al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461: 86-90.
49. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528.
50. David R, Schwarz F, Rimmbach C, Nathan P, Jung J, et al. (2013) Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragment. Basic Res Cardiol 108: 312.
51. Domian IJ, Chiravuri M, van der Meer P, Feinberg AW, Shi X, et al. (2009) Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326: 426-429.
52. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, et al. (2000) Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14: 2540-2548.
53. Fijnvandraat AC, van Ginneken AC, Schumacher CA, Boheler KR, Lekanne Deprez RH, et al. (2003) Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J Mol Cell Cardiol 35: 1461-1472.
54. Arai A, Yamamoto K, Toyama J, (1997) Murine cardiac progenitor cells require visceral embryonic endoderm and primitive streak for terminal differentiation. Dev Dyn 210: 344-353.
55. Miake J, Marban E, Nuss HB, (2003) Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J Clin Invest 111: 1529-1536.
56. Pillekamp F, Reppel M, Dinkelacker V, Duan Y, Jazmati N, et al. (2005) Establishment and characterization of a mouse embryonic heart slice preparation. Cell Physiol Biochem 16: 127-132.
57. Kamkin A, Kiseleva I, Isenberg G, (2003) Ion selectivity of stretch-activated cation currents in mouse ventricular myocytes. Pflugers Arch 446: 220-231.
58. Hong YK, Lange-Asschenfeldt B, Velasco P, Hirakawa S, Kunstfeld R, et al. (2004) VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 18: 1111-1113.
59. Shekhonin BV, Guriev SB, Irgashev SB, Koteliansky VE, (1990) Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol 22: 533-541.
60. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, et al. (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33: 907-921.
61. Hu X, Wang J, Chen J, Luo R, He A, et al. (2007) Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardiothorac Surg 31: 438-443.
62. Liau B, Zhang D, Bursac N, (2012) Functional cardiac tissue engineering. Regen Med 7: 187-206.